Recent news on Pantoprazole

Nycomed sees its drugs in-licenced - report  -  Apr 29, 2007
ReutersFRANKFURT, April 29 (Reuters) - Danish drugmaker Nycomed expects most of its drugs to be in-licenced after patents for its bestselling drug Pantoprazole

Solvay's sales slide and facilities sold to ANI Pharmaceuticals  -  May 9, 2007
Pharma Times (subscription),...due to the expiration of rights to Pantoloc (pantoprazole), although much more positive was the contribution made by cardiovascular drug fenofibrate,

Nycomed seeks new partner to promote Alvesco in the USA  -  May 8, 2007
Pharma Times (subscription),...that will help it fill the void that patent expiries in 2009/10 of its best-selling drug, the gastrointestinal treatment pantoprazole, will create.

Heartburn drugs might promote osteoporosis  -  May 7, 2007
Citrus County Chronicle,Other drugs in this class include Nexium (esomeprazole), Aciphex (rabeprazole), Prevacid (lansoprazole) and protonix (pantoprazole).

QUICK STUDY A weekly digest of new research on major health topics  -  Apr 23, 2007
Washington Post,THIS STUDY randomly assigned 300 adults with H. pylori infection and stomach pain or peptic ulcers to take three antibiotics (pantoprazole,

Sequential Therapy versus Standard Triple-Drug Therapy for ...  -  Apr 16, 2007
Annals of Internal MedicineIntervention: A 10-day sequential regimen (40 mg of pantoprazole, 1 g of amoxicillin, and placebo, each administered twice daily for the first 5 days,

Sequential Therapy Best for Eradicating H. Pylori  -  Apr 17, 2007
Cancerpage.com,However, until now, no double-blind, controlled trials have compared this approach against standard therapy with pantoprazole, clarithromycin,

Sequential Therapy versus Standard Triple-Drug Therapy for ...  -  Apr 16, 2007
Annals of Internal MedicineThe sequential regimen was pantoprazole, amoxicillin, and placebo for 5 days followed by pantoprazole, clarithromycin, and tinidazole for 5 days.

First Quarter Report 2007: Schwarz Pharma with Good Start  -  Apr 25, 2007
PharmaLive.com (press release),On the one hand, this is due to cancellation of the license agreement concerning the gastrointestinal drug Rifun® (pantoprazole) by the licenser.

In the fast lane  -  Apr 25, 2007
Express Pharma,It also has Ocid (Omeprazole), Pantodac (Pantoprazole), Mifegest (Mifeperistone) and Atorva (Atorvastatin) in its product portfolio.

Stop Acid Reflux: How to Get Rid of Your Acid Reflux  -  Apr 24, 2007
American Chronicle,Protonix (Pantoprazole). Pronix is also a proton pump inhibitor you can take to get rid of your acid reflux. It may not be as well known as the others but

Wyeth earnings get a boost in Q1  -  Apr 20, 2007
Pharma Times (subscription),...the gastrointestinal drug Protonix (pantoprazole) dipped 2% to $474 million; and the hormone replacement franchise Premarin (conjugated oestrogens) fell

Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning ...  -  Apr 16, 2007
Drug Newswire (press release),Prevacid(R) (lansoprazole), Prilosec(R) (omeprazole), or Protonix(R) (pantoprazole sodium). Viagra(R) (sildenafil citrate), Levitra(R) (vardenafil HCl),

Independence very much a virtue at Boehringer Ingelheim  -  Mar 28, 2007
Pharma Times (subscription),...the gastrointestinal drug pantoprazole, and noted that Boehringer is always on the look-out for interesting preclinical candidates that its research

Group sales flat but pipeline is promising for Solvay  -  Feb 16, 2007
Pharma Times (subscription),The fourth-quarter decline was principally due to the loss of marketing rights for Pantoloc (pantoprazole) in May and full-year sales of the antiulcerant

Prevnar, Enbrel and Effexor drive Wyeth growth  -  Jan 31, 2007
Pharma Times (subscription),Sales of the gastrointestinal drug Protonix (pantoprazole) were flat at $419.6 million, while Wyeth's Zosyn (piperacillin/tazobactam) antibiotic climbed 21%

Research & Markets: Zanidip (Lercanidipine), an In-house Developed ...  -  Jan 17, 2007
PharmaLive.com (press release),Peptazol (pantoprazole), a proton pump inhibitor for the treatment of ulcers and gastro-oesophageal reflux disease, has demonstrated good year-on-year

Gastrointestinal Medications  -  Jan 5, 2007
Psychosomatics (subscription)1 The five currently available PPIs are omeprazole, lansoprazole, rabeprazole, pantoprazole, and esomeprazole. Although all the PPIs are substituted

Nycomed rolls up its sleeves to start integrating Altana  -  Jan 17, 2007
Pharma Times (subscription),As for the future, Altana's gastrointestinal drug pantoprazole will be the principal growth driver of revenues, at least in the near-term but patent expiry

Nycomed officially launched as combined group  -  Jan 16, 2007
CNW Telbec (Communiqués de presse),In 2006 most Nycomed products showed growth, with Pantoloc(R) (pantoprazole sodium), remaining the largest single product by revenue.

Altana shareholders back pharma sale to Nycomed  -  Dec 20, 2006
Pharma Times (subscription),Dr Schweickart also noted that patent expiry of the gastrointestinal drug pantoprazole in its most important markets in 2009/10 "will create a product gap,

Research Calls: Cadila Healthcare  -  Dec 31, 2006
Business Standard,The company has joint venture partnerships with companies like Altana for supplying Pantoprazole intermediates, Mayne for supplying 8 oncology products and

Hip Fractures Linked To Prolonged Use Of PPI Antacids In The Over 50s  -  Dec 27, 2006
Medical News Today,Proton Pump Inhibitors (PPI) are a range of antacid drugs with names ending in "prazole" such as Pantoprazole (eg branded as Protonix), Lansoprazole (eg

BUY ALTACE, Altace Online, Altace Cheap  -  Dec 25, 2006
Indymedia Colombia,Best phenytoin of amantadine, alprazolam related to analgesic both pantoprazole. Er, one goodhearted norvasc and cox2 drug expectantly waked underneath some

Business News  -  Dec 21, 2006
American Digital Networks (press release),Peptazol (pantoprazole), a proton pump inhibitor for the treatment of ulcers and gastro-oesophageal reflux disease, has demonstrated good year-on-year

ALTANA AG: Extraordinary General Meeting approves sale of ...  -  Dec 20, 2006
Chemie.de (press release),In addition to these external factors, Dr. Schweickart also referred to the internal developments underlying the decision: the patent expiry of Pantoprazole

Altana shareholders back pharma sale to Nycomed  -  Dec 20, 2006
Pharma Times (subscription),Dr Schweickart also noted that patent expiry of the gastrointestinal drug pantoprazole in its most important markets in 2009/10 "will create a product gap,

BUY ALTACE, Altace Online, Altace Cheap  -  Dec 25, 2006
Indymedia Colombia,Best phenytoin of amantadine, alprazolam related to analgesic both pantoprazole. Er, one goodhearted norvasc and cox2 drug expectantly waked underneath some

Business News  -  Dec 21, 2006
American Digital Networks (press release),Peptazol (pantoprazole), a proton pump inhibitor for the treatment of ulcers and gastro-oesophageal reflux disease, has demonstrated good year-on-year

The Medical Minute: Gastroesophageal reflux disease -- beyond ...  -  Nov 29, 2006
Penn State Live,Omeprazole (Prilosec, Zegerid), esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid) and rabeprazole (Aciphex) are PPIs.

The Medical Minute: Gastroesophageal reflux disease -- beyond ...  -  Nov 29, 2006
Penn State Live,Omeprazole (Prilosec, Zegerid), esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid) and rabeprazole (Aciphex) are PPIs. ...

ALTANA Delivers Dynamic 1st Half-Year 2006  Aug 1, 2006
Despite burdens due to the reduction of the reference price of Pantoprazole in Germany, ALTANA Pharma succeeded in increasing first-half earnings before taxes ... -Genetic Engineering News

Altana Says Second-Quarter Net Income Is Little Changed  Aug 1, 2006
The ulcer drug Pantoprazole brings in almost half of Altana's sales. ... Pantoprazole sales rose 13 percent to 743 million euros in the first half. ... -Bloomberg

Altana Says Profit Is Little Changed; Shares Gain (Update1)  Aug 2, 2006
Sales of Altana's ulcer drug Pantoprazole, which brings in almost half of the company's revenue, rose 13 percent to 743 million euros. ... -Bloomberg

Altana Says Profit Unexpectedly Rose; Shares Gain (Update3)  Aug 2, 2006
...boosted last year's results. Sales of Altana's ulcer drug Pantoprazole rose 9.5 percent to 382 million euros, making up almost 40 percent of revenue. ... -Bloomberg

Upper Gastrointestinal Bleeding in the ICU  Aug 23, 2006
He was transfused with 2 units of blood and was started on intravenous pantoprazole (80 mg rapid infusion and 8 mg/hour constant infusion). ... -Medscape (subscription)

Atlana says sues Schwarz over ulcer drug  Aug 9, 2006
Research) have sued rival Schwarz Pharma (SRZG.DE: Quote, Profile, Research), alleging patent infringement on ulcer drug Protonix, or pantoprazole, Altana said ... -Reuters

Denmark's Nycomed interested in Altana - newspaper  Jul 31, 2006
Goldman Sachs (GS.N: Quote, Profile, Research) to explore options for its pharma unit, which is heavily dependent on its flagship anti-ulcer drug, pantoprazole ... -Reuters

Merck Finck Keeps Altana At Hold; Post 2Q  Aug 2, 2006
Says Pantoprazole sales were below expectations. Points out Altana confirmed it FY 06 guidance. Shares +2.1% at EUR45.37. (JAS). Contact us in London. ... -newratings.com



ALTANA 2005: Double-digit Growth in Sales and Net Income  Mar 16, 2006
In 2005, the main sales driver Pantoprazole (Pantozol ® /Protonix ® ), a drug for the treatment of acid-induced gastrointestinal diseases, again achieved a ... - PharmaLive.com

Altana 2005 EBIT in line with consensus; sees double-digit sales ...  Mar 16, 2006
For the company's bread winner, the blockbuster stomach ulcer drug Pantoprazole, also marketed under the name Protonix in the US by Wyeth, Altana sees own ... - Forbes

Altana aims for 3 bln eur sales in pharmaceutical ops in 2008 ...  Mar 16, 2006
Growth should be driven by the company's stomach ulcer drug Pantoprazole, marketed under the brand Protonix in the US by Wyeth. ... - Forbes

Altana proves a bitter pill for Goldman in search for buyer  Apr 6, 2006
Its pharmaceutical division is currently profitable but its success is based on one stomach medicine, Pantoprazole, which loses its patent in 2009, and ... - Telegraph.co.uk

Altana's 06 Outlook Surprises Bear Stearns  Mar 16, 2006
...conservative track record, significant uncertainty over US and European healthcare reforms which could have an impact on main driver Pantoprazole's sales and ... - newratings.com

Schwarz Pharma Surges 10% on Takeover Speculation (Update1)  Mar 29, 2006
...is seeking a partner or a buyer for its pharmaceutical division after setbacks with two new drugs left it overly reliant on ulcer drug Pantoprazole, also known ... - Bloomberg

UPDATE 2-Altana sees pretax rising, chemical unit listing  Mar 16, 2006
Investors are concerned that the company is too dependent on its flagship anti-ulcer drug pantoprazole, which is due to go off patent in 2009/10 and brought in ... - Reuters

UPDATE 4-Altana gives bullish outlook but no news on pharma  Mar 16, 2006
16 (Reuters) - Altana (ALTG.DE: Quote, Profile, Research) gave a bullish outlook for 2006 based on expected strong sales of its star drug pantoprazole but gave ... - Reuters

Goldman Sachs Ups Altana EPS Estimates  Apr 3, 2006
Cites a higher '05 tax base due to a lower-than-expected 4Q tax rate and the repurchase of pantoprazole rights in Canada and Spain. ... - newratings.com

Merck KGaA Makes EU14.9 Billion Offer for Schering AG (Update1)  Mar 12, 2006
Goldman Sachs last year to help it find a pharmaceuticals partner as setbacks with two new asthma drugs increase its reliance on stomach ulcer drug Pantoprazole ... - Bloomberg

Altana 4th-Quarter Net Rose 22%, Helped by Protonix (Update3)  Mar 16, 2006
The drugs were designed to reduce the company's reliance on Protonix, known in Europe as Pantoprazole, which is the company's biggest source of revenue and ... - Bloomberg

Altana sees pretax rising, chemical unit listing  Mar 15, 2006
...acquisitions. It expects sales of its flagship anti-ulcer drug pantoprazole to grow by a significant double-digit percentage. Altana ... - Reuters

Duodenal ulcer tops chart: Study  Mar 9, 2006
...bacterial agents like metronidazole and clarithromycin with strong acid subsidising proton pump inhibitors (PPI) like Omeprazole, Pantoprazole and Rabeprazole. ... - Newindpress (subscription)

Santarus Announces Positive Results with ZEGERID in Nocturnal Acid ...  Mar 8, 2006
..."The results of this clinical study, and our previously published clinical study evaluating ZEGERID and Protonix(R) (pantoprazole) delayed-release capsules in ... - Business Wire



SCHWARZ PHARMA /Full Year Report 2005  Feb 17, 2006
This growth was particularly driven by the promoted drugs Rifun® (pantoprazole; +33%), Atmadisc® (fluticasone/salmeterol; +22%) and Provas® (valsartan; +10 ... - PharmaLive.com,

ASSESSING ADHERENCE TO AN INTRAVENOUS PANTOPRAZOLE GUIDELINE  Jan 25, 2006
BACKGROUND: Despite minimal efficacy data, some institutions frequently use intravenous proton-pump inhibitors (PPIs), such as pantoprazole, for prevention of ... - The Journal of Pharmacy Technology

Altana 4th-Quarter Sales Rose 25%, Helped by Eckart (Update3)  Jan 25, 2006
Revenue from ulcer drug Pantoprazole rose 12 percent to 1.4 billion euros. Pantoprazole is sold by Wyeth in the US as Protonix. ... - Bloomberg

Altana FY 2005 sales up 10 pct to 3.27 bln eur, beating ...  Jan 25, 2006
Pharmaceutical sales in 2005 were lifted by the stomach ulcer drug Pantoprazole, also up 12 pct, to 1.4 bln on the prior year's figure, and beating analysts ... - Forbes

Altana '05 Data, '06 Outlook Slightly Positive  Jan 25, 2006
It's good news the company intends to raise the 05 dividend payout and Altana's target for sales of Pantoprazole in '06 is in line with market estimates. ... - New Ratings

Altana Pharma Sale Not Likely In Near-term  Jan 26, 2006
0859 GMT [Dow Jones] Altana's (AAA) Pantoprazole sales are a positive surprise, says Morgan Stanley, and believes the heartburn drug should continue to benefit ... - New Ratings

Altana sees 2005 pretax in line, sales rise 10 pct  Jan 24, 2006
Its pharmaceuticals unit is heavily dependent on anti-ulcer drug pantoprazole and has experienced setbacks to two key drug hopes, respiratory medicines Alvesco ... - Reuters

German shares extend losses at close on rising oil prices ...  Jan 20, 2006
...company to post solid full year sales, up 9 pct to 3.226 bln from 2.963 bln one year earlier, driven mainly by the stomach ulcer drug Pantoprazole and by ... - Forbes

ALTANA AG: 10th Record Year in Succession  Jan 24, 2006
In 2005, the main sales driver Pantoprazole (Pantozol(R)/Protonix(R)), a drug for the treatment of acid-induced gastrointestinal diseases, again achieved double ... - Genetic Engineering News

New Treatment for Bleeding Ulcers Reduces Surgery, Death Rates  Jan 25, 2006
The trials compared three oral and/or intravenous PPIs — omeprazole, pantoprazole and lansoprazole — to either no drug treatment or alternative acid ... - EndoNurse

Goldman Sachs Cuts Altana To Underperform  Jan 17, 2006
...zero because of the huge estimated adverse earnings impact in 2010," it says, noting that Altana will see the earnings impact of generic pantoprazole in US ... - New Ratings

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional